Major Cerebral Events in Staphylococcus Aureus Infective Endocarditis: Is Anticoagulant Therapy Safe?
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Objectives: To study the impact of anticoagulation on major cerebral events in patients with left-sided Staphylococcus aureus infective endocarditis (IE). Methods: A prospective cohort study; the use of anticoagulation and the relation to major cerebral events was evaluated separately at onset of admission and during hospitalization. Results: Overall, 70 out of 175 patients (40%; 95% CI: 33–47%) experienced major cerebral events during the course of the disease, cerebral ischaemic stroke occured in 59 patients (34%; 95% CI: 27–41%), cerebral infection in 23 patients (14%; 95% CI: 9–19%), and cerebral haemorrhage in 5 patients (3%; 95% CI: 0.5–6%). Patients receiving anticoagulation were less likely to have experienced a major cerebral event at the time of admission (15%) compared with those without anticoagulation (37%, p = 0.009; adjusted OR: 0.27; 95% CI: 0.075–0.96; p = 0.04). In-hospital mortality was 23% (95% CI: 17–29%), and there was no significant difference between those with or without anticoagulation. Conclusions: We found no increased risk of cerebral haemorrhage in S. aureus IE patients receiving anticoagulation. Anticoagulation was associated with a reduced risk of cerebral events before initiation of antibiotics. Data support the continuance of anticoagulation in S. aureus IE patients when indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174
Echocardiography predicts embolic events in infective endocarditis
Di Salvo, G., Habib, G., Pergola, V., Avierinos, J.-F., Philip, E., Casalta, J.-P., Vailloud, J.-M., Derumeaux, G., Gouvernet, J., Ambrosi, P., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01206-7 · Cited by 457
Heiro, M., Nikoskelainen, J., Engblom, E., Kotilainen, E., Marttila, R., & Kotilainen, P. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.18.2781 · Cited by 415
Dickerman, S. A., Abrutyn, E., Barsic, B., Bouza, E., Cecchi, E., Moreno, A., Doco-Lecompte, T., Eisen, D. P., Fortes, C. Q., Fowler, V. G., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.023 · Cited by 374 · cited 1×
“antiplatelet therapy was not associated with a reduced risk of embolic events when used as adjunctive therapy in combination with antibiotics. Accordingly, in our study, the ‘protective’ effect of anticoagulant therapy disappeared after the initiation of antibiotic treatment.Most major cerebral events were diagnosed a…”
ResultSnygg‐Martin, U., Gustafsson, L., Rosengren, L., Alsiö, Å., Ackerholm, P., Andersson, R., & Olaison, L. (2008) · Clinical Infectious Diseases · doi:10.1086/588663 · Cited by 320 · cited 1×
“In IE patients with major cerebral events, ischaemic stroke or cerebral infections are the most frequent findings, which was also the case in our study. Cerebral haemorrhage is another feared complication often related to haemorrhagic transformation of an ischaemic stroke, acute pyogenic arteritis, or in some cases ru…”
BackgroundSelf-citationA randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis
Chan, K.-L., Dumesnil, J. G., Cujec, B., Sanfilippo, A. J., Jue, J., Turek, M. A., Robinson, T. I., & Moher, D. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00829-5 · Cited by 244
Infective Endocarditis Due to Staphylococcus aureus: Deleterious Effect of Anticoagulant Therapy
Tornos, P., Almirante, B., Mirabet, S., Permanyer, G., Pahissa, A., & Soler-Soler, J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.473 · Cited by 214 · cited 1×
“In the past, only a few reports have been published dealing with anticoagulant therapy in IE [ , , ,”
BackgroundFowler, Jr., Sanders, L. L., Kong, L. K., McClelland, R. S., Gottlieb, G. S., Li, J., Ryan, T., Sexton, D. J., Roussakis, G., Harrell, L. J., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515076 · Cited by 196 · cited 1×
“Nevertheless, vegetations were still more frequent in NVIE patients without anticoagulant treatment, and the size of the vegetations was also larger than in NVIE patients who received anticoagulant therapy. The presence and the size of vegetations increase the risk of thromboembolic events, and hence the rate of major…”
ResultImpact of Prior Antiplatelet Therapy on Risk of Embolism in Infective Endocarditis
Anavekar, N. S., Tleyjeh, I. M., Anavekar, N. S., Mirzoyev, Z., Steckelberg, J. M., Haddad, C., Khandaker, M. H., Wilson, W. R., Chandrasekaran, K., & Baddour, L. M. (2007) · Clinical Infectious Diseases · doi:10.1086/513197 · Cited by 138
Cited by
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000029 · Cited by 2,566
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449
Metadata
- Authors
- Rasmussen, R. V., Snygg-Martin, U., Olaison, L., Buchholtz, K., Larsen, C. T., Hassager, C., & Bruun, N. E.
- Venue
- Cardiology
- Publisher
- S. Karger AG
- Published
- 2009
- Volume
- 114
- Issue
- 4
- Pages
- 284-291
- ISSN
- 0008-6312 (ISSN-L)
- 1421-9751
- OpenAlex
- W1974477576
- Cited by
- 41
- References
- 10
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Major Cerebral Events in Staphylococcus Aureus Infective Endocarditis: Is Anticoagulant Therapy Safe? https://app.cochat.ai/papers/10.1159/000235579
- The paper
- Rasmussen, R. V., Snygg-Martin, U., Olaison, L., Buchholtz, K., Larsen, C. T., Hassager, C., & Bruun, N. E. (2009). Major Cerebral Events in Staphylococcus Aureus Infective Endocarditis: Is Anticoagulant Therapy Safe? Cardiology. https://doi.org/10.1159/000235579
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.